Linked Data API

Show Search Form

Search Results

1027423
star this property registered interest false more like this
star this property date less than 2018-12-17more like thismore than 2018-12-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on the cost to NHS England of (a) drugs and (b) devices. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 202790 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-20more like thismore than 2018-12-20
star this property answer text <p>There has been no such assessment.</p> more like this
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property question first answered
less than 2018-12-20T16:21:10.367Zmore like thismore than 2018-12-20T16:21:10.367Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1027425
star this property registered interest false more like this
star this property date less than 2018-12-17more like thismore than 2018-12-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the NHS of procuring (a) chartered flights and (b) rolling ships to stockpile medicines (i) to date, (ii) until 29 March 2019, (iii) after 29 March 2019 in the event that the UK leaves the EU without a deal. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 202792 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-20more like thismore than 2018-12-20
star this property answer text <p>The Department’s ‘no deal’ European Union exit medicines supply contingency plans do not confer any cost to the National Health Service of procuring flights or ships to stockpile medicines either before or beyond 29 March 2019 in the unlikely event that the United Kingdom leaves the European Union without a deal.</p> more like this
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property question first answered
less than 2018-12-20T12:55:43.68Zmore like thismore than 2018-12-20T12:55:43.68Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1039081
star this property registered interest false more like this
star this property date less than 2019-01-10more like thismore than 2019-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of how medicines flown to the UK from Maastricht in preparation for the UK leaving the EU without a deal will reach distributors. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 207258 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-15more like thismore than 2019-01-15
star this property answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the United Kingdom that come from, or via, the European Union or European Economic Area (EEA) asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>We recognise, however, that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers prepare plans to air freight these medicines from the EU, that can be implemented in the event of a ‘no deal’ exit.</p><p> </p><p>Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ exit. We recognise that information received from companies about medicines and supply chains is commercially sensitive; therefore, it is not appropriate to release this information publicly.</p><p> </p><p>We expect supply chains for air-freighted medicines from the EU/EEA to the UK to operate as they do now.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property question first answered
less than 2019-01-15T15:57:02.263Zmore like thismore than 2019-01-15T15:57:02.263Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1056866
star this property registered interest false more like this
star this property date less than 2019-02-07more like thismore than 2019-02-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the memorandum of Dr David Rosser of University Hospitals Birmingham published on 30th January 2019, what steps his Department is taking to ensure adequate distribution of NHS medicines in the event that the UK leaves the EU (a) with a Withdrawal Agreement and (b) without a deal. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 218295 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-12more like thismore than 2019-02-12
star this property answer text <p>Subject to the Withdrawal Agreement being agreed by Parliament, the two-year Implementation Period will begin on exit day. During the Implementation Period, the United Kingdom would the UK would no longer be a Member State of the European Union, but market access for goods, including medicines, would continue on current terms.</p><p> </p><p>During the Implementation Period, it will be the Government’s top priority to negotiate a future economic partnership between the UK and the EU. In the Government’s White Paper we committed to securing the freest and most frictionless trade possible in goods between the UK and the EU and to agree on healthcare arrangements.</p><p> </p><p>Whilst a negotiated deal remains the preferred outcome, it is appropriate that preparations are made for all scenarios. The Government has been accelerating preparations that assure the continuity of supply of National Health Service medicines in the event of the UK leaving the EU without a deal.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/European Economic Area (EEA) asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. We recognise, however, that certain medicines cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>We are working to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and other medical products will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p> </p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property question first answered
less than 2019-02-12T17:39:43.823Zmore like thismore than 2019-02-12T17:39:43.823Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1027758
star this property registered interest false more like this
star this property date less than 2018-12-18more like thismore than 2018-12-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost to the public purse of stockpiling medicines that cannot be refrigerated for the event of the UK leaving the EU without a deal (a) to date, (b) until 29 March 2019 and (c) after 29 March 2019. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 203447 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-07more like thismore than 2019-01-07
star this property answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
203446 more like this
203448 more like this
203449 more like this
star this property question first answered
less than 2019-01-07T16:18:47.123Zmore like thismore than 2019-01-07T16:18:47.123Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1027759
star this property registered interest false more like this
star this property date less than 2018-12-18more like thismore than 2018-12-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the length of time the fridges for stockpiling drugs in preparation for the UK leaving the EU without a deal will need to be procured for; and whether the invitation to tender for those fridges specified the minimum time the refrigeration will be required for. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 203448 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-07more like thismore than 2019-01-07
star this property answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
203446 more like this
203447 more like this
203449 more like this
star this property question first answered
less than 2019-01-07T16:18:47.17Zmore like thismore than 2019-01-07T16:18:47.17Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1027760
star this property registered interest false more like this
star this property date less than 2018-12-18more like thismore than 2018-12-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list the drugs his Department is stockpiling for the UK leaving the EU; and how much his Department has spent to date on stockpiling those drugs. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 203449 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-07more like thismore than 2019-01-07
star this property answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
203446 more like this
203447 more like this
203448 more like this
star this property question first answered
less than 2019-01-07T16:18:47.217Zmore like thismore than 2019-01-07T16:18:47.217Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1027757
star this property registered interest false more like this
star this property date less than 2018-12-18more like thismore than 2018-12-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many days’ worth and what value of drugs which cannot be refrigerated his Department (a) has already stockpiled and (b) is planning to stockpile in preparation the UK leaving the EU without a deal. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 203446 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-07more like thismore than 2019-01-07
star this property answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
203447 more like this
203448 more like this
203449 more like this
star this property question first answered
less than 2019-01-07T16:18:47.06Zmore like thismore than 2019-01-07T16:18:47.06Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1078701
star this property registered interest false more like this
star this property date less than 2019-02-27more like thismore than 2019-02-27
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference article entitled, How will Brexit affect health services in the UK? An updated evaluation, published in the Lancet on 27 February 2019,when his Department plans to publish the (a) medicines and (b) medical devices for which his Department has supply concerns in the event that the UK leaves the EU without a deal. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 226659 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-03-04more like thismore than 2019-03-04
star this property answer text <p>The Department is working closely with trade bodies, product suppliers, the health and care system in England, the devolved administrations and Crown Dependencies, to make detailed plans to ensure the continuation of the supply of medical products to the whole of the United Kingdom in the event of a ‘no deal’ European Union exit.</p><p> </p><p>We have also assessed contract risks associated with potential EU exit in the broader National Health Service and within the devolved administrations, and are working with suppliers to ensure adequate mitigations are in place for non-clinical goods and services (e.g. hospital food, laundry, IT contracts etc).</p><p> </p><p>The key risk to supply is reduced traffic flow at the short straits crossing (i.e. between Calais and Dover or Folkestone), which is where the majority of medicines and other medical products imported from the EU/European Economic Area (EEA) come from. Many companies across all sectors, have already taken measures to protect their own supply chain to avoid the possible delays at the Dover Straits. The Department for Transport has also procured additional ‘roll on roll off’ freight capacity equivalent of around an extra 2,200 heavy goods vehicle per week to help companies in importing medicines and medical products into the UK.</p><p> </p><p>The Government recognises the vital importance of medicines and medical products, including insulin, and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK.</p><p> </p><p>The Government has agreed that medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p> </p><p>In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the EU/EEEA. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the UK ahead of 29 March 2019.</p><p> </p><p>Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
226660 more like this
226661 more like this
star this property question first answered
less than 2019-03-04T17:43:45.153Zmore like thismore than 2019-03-04T17:43:45.153Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
1078703
star this property registered interest false more like this
star this property date less than 2019-02-27more like thismore than 2019-02-27
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the article entitled, How will Brexit affect health services in the UK? An updated evaluation, published on 27 February 2019, whether his Department’s stockpiling contingency plans will ensure medicinal supplies are secured in the long term after the UK leaves the EU. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger remove filter
star this property uin 226661 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-03-04more like thismore than 2019-03-04
star this property answer text <p>The Department is working closely with trade bodies, product suppliers, the health and care system in England, the devolved administrations and Crown Dependencies, to make detailed plans to ensure the continuation of the supply of medical products to the whole of the United Kingdom in the event of a ‘no deal’ European Union exit.</p><p> </p><p>We have also assessed contract risks associated with potential EU exit in the broader National Health Service and within the devolved administrations, and are working with suppliers to ensure adequate mitigations are in place for non-clinical goods and services (e.g. hospital food, laundry, IT contracts etc).</p><p> </p><p>The key risk to supply is reduced traffic flow at the short straits crossing (i.e. between Calais and Dover or Folkestone), which is where the majority of medicines and other medical products imported from the EU/European Economic Area (EEA) come from. Many companies across all sectors, have already taken measures to protect their own supply chain to avoid the possible delays at the Dover Straits. The Department for Transport has also procured additional ‘roll on roll off’ freight capacity equivalent of around an extra 2,200 heavy goods vehicle per week to help companies in importing medicines and medical products into the UK.</p><p> </p><p>The Government recognises the vital importance of medicines and medical products, including insulin, and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK.</p><p> </p><p>The Government has agreed that medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p> </p><p>In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the EU/EEEA. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the UK ahead of 29 March 2019.</p><p> </p><p>Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond remove filter
star this property grouped question UIN
226659 more like this
226660 more like this
star this property question first answered
less than 2019-03-04T17:43:45.28Zmore like thismore than 2019-03-04T17:43:45.28Z
unstar this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this